MARKET

ABMD

ABMD

Abiomed
NASDAQ

Real-time Quotes | Nasdaq Last Sale

263.84
+8.62
+3.38%
After Hours: 263.84 0 0.00% 16:41 07/02 EDT
OPEN
256.11
PREV CLOSE
255.22
HIGH
266.35
LOW
255.43
VOLUME
518.83K
TURNOVER
--
52 WEEK HIGH
285.77
52 WEEK LOW
119.01
MARKET CAP
11.86B
P/E (TTM)
59.58
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ABMD stock price target is 214.40 with a high estimate of 250.00 and a low estimate of 152.00.

EPS

ABMD News

More
MiMedx Announces Concurrent $150 Million Private Equity and Debt Financings
GlobeNewswire · 1d ago
Study Finds 84% Survival Rate in Patients in Cardiogenic Shock and Other Challenging Cardiac Conditions with the New Impella 5.5 with SmartAssist
Business Wire · 2d ago
These stocks, including Tesla and Apple, are the real winners for the second quarter of 2020
marketwatch.com · 2d ago
10 Semi-Controversial Traits Of Some Of The Best Stocks
Seeking Alpha - Article · 5d ago
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Enphase Energy, Inc. (ENPH)
Business Wire · 06/25 16:00
Abiomed: Not A Costly Affair After All
Seeking Alpha - Article · 06/18 15:33
Abiomed Or DexCom: Selecting The Best Medical Devices Stock Now
Seeking Alpha - Article · 06/17 23:01
Edited Transcript of ABMD earnings conference call or presentation 30-Apr-20 12:00pm GMT
Thomson Reuters StreetEvents · 06/17 15:29

Industry

Advanced Medical Equipment & Technology
+1.07%
Healthcare Equipment & Supplies
+0.92%

Hot Stocks

Symbol
Price
%Change

About ABMD

ABIOMED, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the segment of the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. The Company develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and end-organs and/or temporarily performing the pumping function of the heart. The Company's product portfolio includes the Impella 2.5, Impella CP, Impella RP, Impella LD, Impella 5.0 and AB5000. The Company's products are used in the cardiac catheterization lab (cath lab), by interventional cardiologists, the electrophysiology lab, the hybrid lab and in the heart surgery suite by heart surgeons.
More

Webull offers kinds of ABIOMED, Inc. stock information, including NASDAQ:ABMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ABMD stock methods without spending real money on the virtual paper trading platform.